Scinai Immunotherapeutics (SCNI) Assets (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Assets for 2 consecutive years, with $11.6 million as the latest value for Q4 2025.
- Quarterly Assets fell 13.55% to $11.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.6 million through Dec 2025, down 13.55% year-over-year, with the annual reading at $11.6 million for FY2025, 13.55% down from the prior year.
- Assets hit $11.6 million in Q4 2025 for Scinai Immunotherapeutics, down from $13.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $13.4 million in Q4 2024 to a low of $11.6 million in Q4 2025.